Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis

• Published in: Parasitology research (1987) 2016-10, Vol.115 (10), p.3795-3806
• Main Authors: Liu, Fang, Cheng, Weisheng, Pappoe, Faustina, Hu, Xiaodong, Wen, Huiqin, Luo, Qingli, Wang, Shushu, Deng, Fang, Xie, Yuanyuan, Xu, Yuanhong, Shen, Jilong
• Format: Article
• Language: English
• Subjects: Animals; Arthritis; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - immunology; Biomedical and Life Sciences; Biomedicine; Cattle; Collagen Type II - adverse effects; Collagen Type II - immunology; Cystatins - administration & dosage; Cystatins - immunology; Cytokines; Health aspects; Helminth Proteins - administration & dosage; Helminth Proteins - immunology; Humans; Immunology; Inflammation; Interleukin-10 - genetics; Interleukin-10 - immunology; Interleukin-17 - genetics; Interleukin-17 - immunology; Interleukin-4 - genetics; Interleukin-4 - immunology; Interleukin-6 - immunology; Male; Medical Microbiology; Mice; Mice, Inbred DBA; Microbiology; Original Paper; Physiological aspects; Schistosoma; Schistosoma japonicum; Schistosoma japonicum - chemistry; Schistosoma japonicum - immunology; Statins; Th17 Cells - immunology; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - immunology
• ISSN: 0932-0113; 1432-1955
• DOI: 10.1007/s00436-016-5140-0

Recombinant SjCystatin (rSjCystatin), a recombinant protein of Schistosoma japonicum cystatin, has been reported to have an effect on immunoregulation mediated by IL-10 induction. Rheumatoid arthritis (RA) is a common autoimmune inflammatory arthropathy, and recombinant immune-modulating drugs for RA treatment are under development. We aimed to study the putative immune regulation of rSjCystatin and its prophylactic/therapeutic effects on murine collagen-induced arthritis (CIA). CIA was induced in DBA/1 mice by inoculation with bovine collagen II (CII). rSjCystatin was administered prior or post development of CIA. The severity of CIA was assessed using established clinical and histopathological scoring systems. The incidence was also determined. The CII-specific antibodies in sera and cytokines in splenocyte culture supernatants were measured by ELISA. Th1/Th2/Th17 cells and Tregs development in splenocytes were monitored by flow cytometry. The inflammatory mediators in the diseased joint were semiquantitated by qPCR. Prophylactic injection of rSjCystatin attenuated paw clinical scores, incidence, and histopathology scores of joints in CIA mice. The arthritis-alleviative effects were closely associated with the augmentation of IL-4, IL-10, and collagen-specific IgG1, and with the distinct reduction of IFN-γ, collagen-specific IgG2a, and the marked decrease of proinflammatory cytokines IL-6, IL-17, and TNF-α and RANKL. The data indicate that rSjCystatin may prevent cartilage destruction and inflammation of joints in CIA mice. The effects are related to the inhibitory modulation of Th1 and Th17 and upregulation of Tregs and Th2 via a shift of cytokines profiling from Th1 to Th2 response.